SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGPBiotechnology
+$0.45 today
- Market cap
- $993.14M
- Beta
- -0.34
- P/E (TTM)
- -14.1
- EPS (TTM)
- -$1.32
Volume 0.10M
Average 0.09M
SGP Tax Assets
Deferred tax assets that can reduce taxes payable in future periods.
SpyGlass Pharma, Inc. Common StockNASDAQ: SGP
Tax Assets · Q1 FY2026 · quarter ended Mar 2026
Tax assets of $0 in Q1 FY2026
Q1 FY2026 tax assets was $0.
Context
- Tax assets amounted to 0.0% of total assets at the end of Q1 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Tax Assets history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Tax Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
Tax Assets vs competitors
How SGP compares with its peers on the latest reported figures
- Peers report in different currencies, so tax assets is compared through growth and share of total assets rather than absolute size.
- Tax assets amounts to 0.0% of total assets for SGP, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $952M USD | -2.2% | +0.3% | 6.9% | |
| Sep 2026 | $508M USD | +6.6% | — | 1.6% | |
| Apr 2026 | $1.09M USD | -72.8% | +15.0% | 0.2% | |
SGPSpyGlass Pharma, Inc. Common Stock | Mar 2026 | $0 USD | — | — | 0.0% |
| Jun 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | CHF 0 CHF | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding SGP) | — | -2.2% | +7.6% | 0.0% | |
Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
SpyGlass Pharma, Inc. Common Stock
NASDAQ:SGP
Intrinsic Alpha fair value
Locked
Current Price
$29.68
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.